Concern about the possible association of postmenopausal hormone use with risk of breast cancer has been increased by several recent studies. Little data are available on the long term effects of progestin used in conjunction with estrogen which has become so common in recent years. Moreover, because of the benefits of estrogen for other diseases, it is important to precisely quantify any risk related to breast cancer. We propose to extend our ongoing multicenter, population-based case-control study of breast cancer to evaluate the relationships between postmenopausal hormone use and alcohol consumption. We will specifically assess use of estrogens with progestins, duration and currency of hormone use, and the interrelationships with alcohol intake. We will interview 5,000 women with newly diagnosed breast cancer identified from the tumor registries of Wisconsin, Massachusetts, and New Hampshire, and 5,000 population-based controls drawn from driver's license and medicare lists. The process will be similar to our current study which achieved a response rate of about 90% for cases and controls and enrolled more than the projected number of subjects. By extending our current study now, we can take advantage of an efficient process developed over the past several years and a well trained team. The large sample is required because of the need for precise estimates for what likely will be modest associations and because progestin plus estrogen use of sufficient duration for study is still relatively uncommon. The University of Wisconsin Clinical Cancer Center and the Harvard School of Public Health will continue to coordinate the study and have submitted separate applications with identical research plans.
| Jewett, Patricia I; Gangnon, Ronald E; Elkin, Elena et al. (2018) Geographic access to mammography facilities and frequency of mammography screening. Ann Epidemiol 28:65-71.e2 |
| Shiyanbola, Oyewale O; Arao, Robert F; Miglioretti, Diana L et al. (2017) Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiol Biomarkers Prev 26:1753-1760 |
| Passarelli, Michael N; Newcomb, Polly A; Hampton, John M et al. (2016) Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. J Clin Oncol 34:1315-22 |
| Wyszynski, Asaf; Hong, Chi-Chen; Lam, Kristin et al. (2016) An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Hum Mol Genet 25:3863-3876 |
| Schmidt, Marjanka K; Hogervorst, Frans; van Hien, Richard et al. (2016) Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. J Clin Oncol 34:2750-60 |
| Zeng, Chenjie (see original citation for additional authors) (2016) Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Res 18:64 |
| Mavaddat, Nasim; Pharoah, Paul D P; Michailidou, Kyriaki et al. (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 107: |
| Thrift, Aaron P; Gong, Jian; Peters, Ulrike et al. (2015) Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev 24:1024-31 |
| Sprague, Brian L; Gangnon, Ronald E; Hampton, John M et al. (2015) Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies. Am J Epidemiol 181:956-69 |
| Warren Andersen, Shaneda; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2014) Reproductive windows, genetic loci, and breast cancer risk. Ann Epidemiol 24:376-82 |
Showing the most recent 10 out of 131 publications
